August 19, 2014 – Curant Health Director of Hepatitis Program, Amy Hampton, in POZ – According to the Centers for Disease Control and Prevention (CDC), more than 1.1 million people in the United States are living with HIV, and around 25 percent of those are also coinfected with hepatitis C (HCV). That number is even more alarming when you consider that consequences from HCV infection are the leading cause of death among HIV patients.
HIV/HCV coinfection is known to accelerate HCV disease progression and present a greater risk of severe liver damage. That’s why the coinfected patient population will most likely be one of the first to be treated and stands to see great benefit from advances in HCV treatment that are capable of eliminating the virus entirely in over 90 percent of infected individuals.
To read Amy’s full article, visit Poz.
To learn more about Curant Health, contact Kristin Lindsey, Marketing Director, at email@example.com.